LOS ANGELES, April 25, 2018 -- Top-Down Analytics (TDA), a Los Angeles-based market research and management consulting firm has announced a new market report entitled Metabolomics 2018: Charged with Massive Potential.
Over the past five years, the market for metabolomics research has increased dramatically, with LC/MS and NMR leading the charge in the areas of biomarker discovery, phenotyping, toxicology, and personalized medicine. Demand for instruments has been robust, particularly with researchers perpetually seeking next-generation technologies and methods.
This report on metabolomics reveals the current state of the market, while also elucidating overall trends and key market drivers, addressing challenges, and uncovering existing opportunities. The market for the analytical systems and related products used for metabolomics research is estimated to have been more than $750 million in 2017. “With increased funding for metabolomics research, it is an exciting time for instrument manufacturers,” said Glenn Cudiamat, general manager at TDA. “The level of activity in metabolomics research is following the same trajectory that activity in proteomics did about a decade ago.”
The report characterizes the demand for metabolomics systems and consumables, segmented by the following:
- Instrumentation technology/product
- Application type
- Region
- Lab industry/sector
Other features of the report include:
- An end-user survey of metabolomics laboratories to determine current usage patterns, needs, and expectations
- Identification and description of the factors providing opportunities and challenges that will affect growth of the overall market as well as its relevant segments
- Identification of the leading manufacturers and products, and their impact on the market
- A timeline of developments in the market, including regulatory developments, product launches, partnerships, and mergers and acquisitions
- A forecast of the growth of the metabolomics market and its segments through 2022
For more information and to order your copy of TDA’s Metabolomics 2018 report, visit: http://www.tdaresearch.com/store/p96/Metabolomics_2018_%28Corporate_License%29.html
About Top-Down Analytics
Top-Down Analytics (TDA) is a management consulting firm focused on providing strategic services for scientific technology companies. We are specialized in scientific markets for laboratory instrumentation, technologies and applications, from clinical research and industrial instruments to process control, security, and other applications of analytical technologies.
Contact
Glenn Cudiamat
General Manager
Top-Down Analytics
888.953.5655 x88 [office]
310.871.3768 [mobile]


Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand 



